Literature DB >> 19189107

Modeling the mechanism of postantibiotic effect and determining implications for dosing regimens.

Patricia Geli1.   

Abstract

A stochastic model is proposed to explain one possible underlying mechanism of the postantibiotic effect (PAE). This phenomenon, of continued inhibition of bacterial growth after removal of the antibiotic drug, is of high relevance in the context of optimizing dosing regimens. One clinical implication of long PAE lies in the possibility of increasing intervals between drug administrations. The model describes the dynamics of synthesis, saturation and removal of penicillin binding proteins (PBPs). High fractions of saturated PBPs are in the model associated with a lower growth capacity of bacteria. An analytical solution for the bivariate probability of saturated and unsaturated PBPs is used as a basis to explore optimal antibiotic dosing regimens. Our finding that longer PAEs do not necessarily promote for increased intervals between doses, might help for our understanding of data provided from earlier PAE studies and for the determination of the clinical relevance of PAE in future studies.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19189107     DOI: 10.1007/s00285-009-0249-8

Source DB:  PubMed          Journal:  J Math Biol        ISSN: 0303-6812            Impact factor:   2.259


  32 in total

1.  A combined in vivo pharmacokinetic-in vitro pharmacodynamic approach to simulate target site pharmacodynamics of antibiotics in humans.

Authors:  S Delacher; H Derendorf; U Hollenstein; M Brunner; C Joukhadar; S Hofmann; A Georgopoulos; H G Eichler; M Müller
Journal:  J Antimicrob Chemother       Date:  2000-11       Impact factor: 5.790

2.  Concentration-dependent selection of small phenotypic differences in TEM beta-lactamase-mediated antibiotic resistance.

Authors:  M C Negri; M Lipsitch; J Blázquez; B R Levin; F Baquero
Journal:  Antimicrob Agents Chemother       Date:  2000-09       Impact factor: 5.191

Review 3.  Non-compliance with antibiotic therapy for acute community infections: a global survey.

Authors:  Jean-Claude Pechère; Dyfrig Hughes; Przemyslaw Kardas; Giuseppe Cornaglia
Journal:  Int J Antimicrob Agents       Date:  2007-01-16       Impact factor: 5.283

4.  Pharmacokinetic-pharmacodynamic modeling of activity of ceftazidime during continuous and intermittent infusion.

Authors:  J W Mouton; A A Vinks; N C Punt
Journal:  Antimicrob Agents Chemother       Date:  1997-04       Impact factor: 5.191

5.  High rate of non-compliance with anti-tuberculosis treatment despite a retrieval system: a call for implementation of directly observed therapy in Saudi Arabia.

Authors:  M S Al-Hajjaj; I M Al-Khatim
Journal:  Int J Tuberc Lung Dis       Date:  2000-04       Impact factor: 2.373

6.  The paradox of using a 7 day antibacterial course to treat urinary tract infections in the community.

Authors:  R Cheung; C M Sullens; D Seal; J Dickins; P W Nicholson; A A Deshmukh; M J Denham; S M Dobbs
Journal:  Br J Clin Pharmacol       Date:  1988-10       Impact factor: 4.335

7.  Comparative study with enoxacin and netilmicin in a pharmacodynamic model to determine importance of ratio of antibiotic peak concentration to MIC for bactericidal activity and emergence of resistance.

Authors:  J Blaser; B B Stone; M C Groner; S H Zinner
Journal:  Antimicrob Agents Chemother       Date:  1987-07       Impact factor: 5.191

8.  Isoniazid uptake and growth inhibition of Mycobacterium tuberculosis in relation to time and concentration of pulsed drug exposures.

Authors:  W H Beggs; J W Jenne
Journal:  Tubercle       Date:  1969-12

9.  Antibiotic noncompliance and waste in upper respiratory infections and acute diarrhea.

Authors:  H Reyes; H Guiscafré; O Muñoz; R Pérez-Cuevas; H Martinez; G Gutiérrez
Journal:  J Clin Epidemiol       Date:  1997-11       Impact factor: 6.437

10.  Effects of intervention on antibiotic compliance in patients in general practice.

Authors:  J Cockburn; A L Reid; J A Bowman; R W Sanson-Fisher
Journal:  Med J Aust       Date:  1987-10-05       Impact factor: 7.738

View more
  1 in total

1.  Computational pharmacokinetics/pharmacodynamics of rifampin in a mouse tuberculosis infection model.

Authors:  Michael A Lyons; Anne J Lenaerts
Journal:  J Pharmacokinet Pharmacodyn       Date:  2015-05-31       Impact factor: 2.745

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.